- Home
- MNPR vs REKR Comparison
MNPR vs REKR Comparison
Compare MNPR & REKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- REKR
- Stock Information
- Founded
- MNPR 2014
- REKR 2017
- Country
- MNPR United States
- REKR United States
- Employees
- MNPR N/A
- REKR N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- REKR Telecommunications Equipment
- Sector
- MNPR Health Care
- REKR Telecommunications
- Exchange
- MNPR Nasdaq
- REKR Nasdaq
- Market Cap
- MNPR 95.5M
- REKR 79.2M
- IPO Year
- MNPR 2019
- REKR N/A
- Fundamental
- Price
- MNPR $18.09
- REKR $0.90
- Analyst Decision
- MNPR Strong Buy
- REKR Buy
- Analyst Count
- MNPR 3
- REKR 1
- Target Price
- MNPR $27.33
- REKR N/A
- AVG Volume (30 Days)
- MNPR 1.5M
- REKR 1.1M
- Earning Date
- MNPR 11-08-2024
- REKR 11-14-2024
- Dividend Yield
- MNPR N/A
- REKR N/A
- EPS Growth
- MNPR N/A
- REKR N/A
- EPS
- MNPR N/A
- REKR N/A
- Revenue
- MNPR N/A
- REKR $43,817,000.00
- Revenue This Year
- MNPR N/A
- REKR $55.93
- Revenue Next Year
- MNPR N/A
- REKR $57.14
- P/E Ratio
- MNPR N/A
- REKR N/A
- Revenue Growth
- MNPR N/A
- REKR 44.46
- 52 Week Low
- MNPR $1.37
- REKR $0.89
- 52 Week High
- MNPR $38.50
- REKR $3.92
- Technical
- Relative Strength Index (RSI)
- MNPR 60.19
- REKR 31.36
- Support Level
- MNPR $16.26
- REKR $1.10
- Resistance Level
- MNPR $19.70
- REKR $1.15
- Average True Range (ATR)
- MNPR 2.15
- REKR 0.07
- MACD
- MNPR -0.07
- REKR -0.01
- Stochastic Oscillator
- MNPR 74.36
- REKR 1.93
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin for the treatment of soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About REKR Rekor Systems Inc.
Rekor Systems Inc is a United States-based company. The company is engaged in providing real-time roadway intelligence through AI-driven decisions. The firm uses artificial intelligence to analyze video streams and transform them into AI-driven decisions. The company's technology and machine learning models power all solutions, including Rekor Command for transportation management, Rekor Discover for urban mobility, and Rekor Scout for public safety, and commercial use. Its geographical segments are the United States and Others, of which the majority of its revenue comes from the United States.